Related Experiment Videos
[Inhibition of angiogenesis on the chicken chorioallantoic membrane by Ets 1 antisense oligodeoxyribonucleotides]
Abstract:
The Ets 1 transcription factor, the founder of the ets gene family of transcriptional regulators, has strongly been supposed to play a role in angiogenesis under both physiological and pathological conditions including tumor vascularization. An in vivo role has nevertheless not yet been proven. We therefore investigated whether an Ets 1 antisense oligodesoxynucleotide (ODN) blockade effectively inhibits in vivo angiogenesis in the chicken chorioallantois membrane-assay. We used a 20-mer phosphorothioate directed against the AUG initiation codon and a short 3' sequence of the c-ets 1 mRNA (5'-AGATCGACGGCCGCCTTCAT-3') in order to block Ets 1 expression. Three quantities of either antisense or negative control sense ODNs were directly applied on the chorioallantois membrane on day five of development and results evaluated on day seven. No effect on angiogenesis was seen in the antisense group treated with 2.5 micrograms ODN/egg compared to the sense control group. In contrast chorioallantoic blood vessel numbers and diameters were considerably reduced after application of 5 micrograms antisense ODN. 10 micrograms of either antisense or sense ODNs turned out to be toxic: all 6 embryos had died on day seven. Our results are the first proof that the Ets 1 transcription factor is actually necessary for the regulation of in vivo angiogenesis. Its role is probably not restricted to development but also concerns new blood vessel formation during chronic inflammation and tumor vascularization.
Insights
The Ets 1 transcription factor is crucial for in vivo angiogenesis, as demonstrated by blocking its expression with antisense oligodesoxynucleotides (ODNs). This study provides the first in vivo proof of Ets 1
Area of Science:
- Molecular Biology
- Developmental Biology
- Oncology
Context:
- Angiogenesis, the formation of new blood vessels, is vital for development and implicated in diseases like cancer.
- The Ets 1 transcription factor, a key regulator, is hypothesized to play a role in angiogenesis.
- Previous studies lacked in vivo evidence for Ets 1's role in blood vessel formation.
Purpose:
- To investigate the in vivo necessity of Ets 1 for angiogenesis.
- To determine if Ets 1 blockade using antisense oligodesoxynucleotides (ODNs) inhibits angiogenesis.
- To establish the role of Ets 1 in physiological and pathological vascularization.
Summary:
- Ets 1 antisense ODNs were applied to chicken chorioallantois membranes to inhibit Ets 1 expression.
- A dose of 5 micrograms of antisense ODN significantly reduced blood vessel number and diameter.
- Higher doses (10 micrograms) of ODNs proved toxic to embryos, while lower doses (2.5 micrograms) showed no effect.
Impact:
- This study provides the first in vivo evidence that Ets 1 is essential for regulating angiogenesis.
- The findings suggest Ets 1's role extends beyond development to include neovascularization in chronic inflammation and tumors.
- This research opens avenues for therapeutic strategies targeting Ets 1 in diseases characterized by aberrant angiogenesis.